Literature DB >> 7557611

Laparoscopic surgical staging of ovarian cancer.

J M Childers1, J Lang, E A Surwit, K D Hatch.   

Abstract

The feasibility of laparoscopic staging in patients with ovarian cancer was undertaken prospectively to determine the ability to adequately evaluate both the intraperitoneal cavity and the retroperitoneal lymph nodes. Two groups of ovarian cancer patients were evaluated: those with optimally debulked advanced disease undergoing second-look procedures and those with presumed stage I disease undergoing surgical staging. Twenty-four of the 44 laparoscopic second-look procedures (56%) were positive for persistent disease. Five of these patients had microscopic disease only, in the omentum, washings, pelvic peritoneum, and in para-aortic lymph nodes (2 patients). In the group of 14 patients undergoing staging for presumed early ovarian carcinoma, metastatic disease was discovered in 8 (57%) patients. Two patients had peritoneal washings positive for adenocarcinoma; 3 had pelvic disease, 1 confined to a fallopian tube and 2 to the pelvic peritoneum; and 3 patients had para-aortic lymph nodes positive for metastatic adenocarcinoma. There were no serious complications in this category. The average hospital stay was 1.6 days. Laparoscopic staging appears to be an accurate staging technique, and further investigation into the validity of this approach is warranted.

Entities:  

Mesh:

Year:  1995        PMID: 7557611     DOI: 10.1006/gyno.1995.1263

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

Review 1.  Role of minimally invasive surgery in early ovarian cancer.

Authors:  Chul Kwon Lim; Dae Yeon Kim; Angela Cho; Ji-Yeong Choi; Jeong-Yeol Park; Yong-Man Kim
Journal:  Gland Surg       Date:  2021-03

2.  Laparoscopic surgical staging of early ovarian cancer.

Authors:  Sarah Weber; Christopher K McCann; David M Boruta; John O Schorge; Whitfield B Growdon
Journal:  Rev Obstet Gynecol       Date:  2011

3.  Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update.

Authors:  Mohamed Mabrouk; Michael Frumovitz; Marilyn Greer; Sheena Sharma; Kathleen M Schmeler; Pamela T Soliman; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2009-01-12       Impact factor: 5.482

Review 4.  Early ovarian cancer.

Authors:  G Coukos; S C Rubin
Journal:  Curr Treat Options Oncol       Date:  2000-06

Review 5.  Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals.

Authors:  F C Muñoz-Casares; S Rufián; M J Rubio; E Lizárraga; C Díaz-Iglesias; E Aranda; R Ciria; J Muntané; P Barrios; J Torres-Melero; S González-Moreno; L González-Bayón; B Camps; P Bretcha; J Farré; G Ortega-Pérez; A Gómez-Portilla
Journal:  Clin Transl Oncol       Date:  2007-10       Impact factor: 3.405

Review 6.  Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.

Authors:  Frederico S Falcetta; Theresa A Lawrie; Lídia Rf Medeiros; Maria Ines da Rosa; Maria I Edelweiss; Airton T Stein; Alice Zelmanowicz; Anaelena B Moraes; Roselaine R Zanini; Daniela D Rosa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

7.  Laparoscopic management of adnexal masses.

Authors:  E Serur; P L Emeney; D W Byrne
Journal:  JSLS       Date:  2001 Apr-Jun       Impact factor: 2.172

8.  The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.

Authors:  Farr R Nezhat; Shaghayegh M DeNoble; Connie S Liu; Jennifer E Cho; Douglas N Brown; Linus Chuang; Herbert Gretz; Prakash Saharia
Journal:  JSLS       Date:  2010 Apr-Jun       Impact factor: 2.172

9.  Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.

Authors:  Guldeniz Aksan Desteli; Murat Gultekin; Alp Usubutun; Kunter Yuce; Ali Ayhan
Journal:  World J Surg Oncol       Date:  2010-11-30       Impact factor: 2.754

10.  Adnexal masses suspected to be benign treated with laparoscopy.

Authors:  Richard H Demir; Greg J Marchand
Journal:  JSLS       Date:  2012 Jan-Mar       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.